Minomo, A., Ishima, Y., Chuang, V. T. G., Suwa, Y.
, Kragh-Hansen, U., Narisoko, T., Morioka, H., Maruyama, T. & Otagiri, M. (2013).
Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatment.
BBA General Subjects,
1830, 2917-2923.
Mohnke, S., Erk, S., Schnell, K., Schütz, C., Romanczuk-Seiferth, N., Grimm, O., Haddad, L., Pöhland, L., Garbusow, M., Schmitgen, M. M., Kirsch, P., Esslinger, C., Rietschel, M., Witt, S. H., Nöthen, M. M., Cichon, S.
, Mattheisen, M., Mühleisen, T., Jensen, J. ... Walter, H. (2013).
Further Evidence for the Impact of a Genome-Wide-Supported Psychosis Risk Variant in ZNF804A on the Theory of Mind Network.
Neuropsychopharmacology.
https://doi.org/10.1038/npp.2013.321